Brought to you by 
Abbott to market and sell Coherex's FlatStent PFO device
29 Sep 2020
Executive Summary
In multi-year agreement, cardiovascular device company Coherex Medical licensed Abbott exclusive rights to market and distribute its Coherex FlatStent EF patent foramen ovale (PFO) closure system worldwide, except in the US and Japan.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott to market and sell Coherex's FlatStent PFO device
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice